Health care pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 health care pharmaceutical companies ranked by one-year price change, at +395%, ahead of Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%). Figures as of 19 Nov 2026, 21:37 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+395%
- Median
- +27.0%
- Combined market value
- SGD 6.41T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +395% | SGD 6.4B | SGD 18.37 | 3.34% up | 395% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +332% | SGD 12B | SGD 126.14 | 3.77% down | 332% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +255% | SGD 8.5B | SGD 126.06 | 1.91% up | 255% up | ||
| 4 | VeradermicsMANE · Health Care | +231% | SGD 6.8B | SGD 160.72 | 0.38% down | 231% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +168% | SGD 5.2B | SGD 38.09 | 1.24% up | 168% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +129% | SGD 9.5B | SGD 120.85 | 1.59% down | 129% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | +117% | SGD 12.7B | SGD 83.83 | 1.88% down | 117% up | ||
| 8 | Dianthus TherapeuticsDNTH · Health Care | +108% | SGD 6.2B | SGD 109.60 | 1.01% up | 108% up | ||
| 9 | ViatrisVTRS · Health Care | +99.0% | SGD 29.4B | SGD 25.69 | 1.97% down | 99% up | ||
| 10 | Roivant SciencesROIV · Health Care | +91.1% | SGD 36.5B | SGD 50.34 | 0.59% up | 91% up | ||
| 11 | Amneal PharmaceuticalsAMRX · Health Care | +90.0% | SGD 9.6B | SGD 27.64 | 2.24% down | 90% up | ||
| 12 | Praxis Precision MedicinesPRAX · Health Care | +86.0% | SGD 11.2B | SGD 401.70 | 1.87% up | 86% up | ||
| 13 | Edgewise TherapeuticsEWTX · Health Care | +85.9% | SGD 5.8B | SGD 53.19 | 0.48% down | 86% up | ||
| 14 | Royalty PharmaRPRX · Health Care | +78.9% | SGD 50.3B | SGD 87.50 | 1.38% down | 79% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | +73.9% | SGD 58.1B | SGD 49.80 | 8.74% down | 74% up | ||
| 16 | GenmabGMAB · Health Care | +69.7% | SGD 40.9B | SGD 66.35 | 0.75% up | 70% up | ||
| 17 | AlkermesALKS · Health Care | +66.2% | SGD 10B | SGD 59.67 | 1.43% down | 66% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +51.3% | SGD 88.4B | SGD 27.66 | 0.66% up | 51% up | ||
| 19 | Protagonist TherapeuticsPTGX · Health Care | +51.0% | SGD 10.5B | SGD 160.24 | 2.47% down | 51% up | ||
| 20 | Ligand PharmaceuticalsLGND · Health Care | +50.1% | SGD 7.4B | SGD 370.74 | 3.94% down | 50% up | ||
| 21 | Merck & CoMRK · Health Care | +45.1% | SGD 423B | SGD 171.60 | 3.61% down | 45% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | +44.7% | SGD 6B | SGD 62.41 | 3.86% down | 45% up | ||
| 23 | Belite BioBLTE · Health Care | +43.1% | SGD 7.9B | SGD 195.12 | 3.33% down | 43% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +41.0% | SGD 19.6B | SGD 305.50 | 4.57% down | 41% up | ||
| 25 | Johnson & JohnsonJNJ · Health Care | +34.3% | SGD 830.9B | SGD 345.16 | 2.04% down | 34% up | ||
| 26 | Mirum PharmaceuticalsMIRM · Health Care | +33.7% | SGD 8.1B | SGD 123.40 | 3.27% up | 34% up | ||
| 27 | Eli LillyLLY · Health Care | +32.5% | SGD 1.55T | SGD 1,745.70 | 2.29% down | 33% up | ||
| 28 | Bristol-Myers SquibbBMY · Health Care | +29.6% | SGD 154.1B | SGD 75.38 | 2.05% down | 30% up | ||
| 29 | Ascendis PharmaASND · Health Care | +29.0% | SGD 21.7B | SGD 330.71 | 5.32% down | 29% up | ||
| 30 | Regeneron PharmaceuticalsREGN · Health Care | +28.3% | SGD 123.4B | SGD 1,192.99 | 2.35% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +27.0% | SGD 170.6B | SGD 672.71 | 2.94% down | 27% up | ||
| 32 | Elanco Animal HealthELAN · Health Care | +25.7% | SGD 17B | SGD 33.97 | 1.54% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +24.8% | SGD 369B | SGD 195.38 | 2.57% down | 25% up | ||
| 34 | AbbVieABBV · Health Care | +24.7% | SGD 647.6B | SGD 366.35 | 0.86% down | 25% up | ||
| 35 | United TherapeuticsUTHR · Health Care | +21.6% | SGD 30.8B | SGD 722.38 | 3.16% down | 22% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +20.7% | SGD 19.7B | SGD 101.01 | 0.22% up | 21% up | ||
| 37 | Rhythm PharmaceuticalsRYTM · Health Care | +18.3% | SGD 10.5B | SGD 150.91 | 1.88% down | 18% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | +17.1% | SGD 15.4B | SGD 79.36 | 0.02% down | 17% up | ||
| 39 | BeOne MedicinesONC · Health Care | +15.5% | SGD 59B | SGD 516.43 | 0.97% down | 16% up | ||
| 40 | PfizerPFE · Health Care | +15.0% | SGD 202.8B | SGD 35.58 | 1.85% down | 15% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +13.2% | SGD 8B | SGD 56.40 | 1.25% up | 13% up | ||
| 42 | Dr. Reddy's LaboratoriesRDY · Health Care | +7.77% | SGD 16B | SGD 19.16 | 1.00% down | 8% up | ||
| 43 | GSKGSK · Health Care | +5.36% | SGD 123.8B | SGD 61.79 | 1.56% down | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +0.79% | SGD 351.5B | SGD 226.64 | 1.87% down | 1% up | ||
| 45 | GrifolsGRFS · Health Care | +0.47% | SGD 7.2B | SGD 10.59 | 3.19% down | 0% up | ||
| 46 | SanofiSNY · Health Care | -3.62% | SGD 142.9B | SGD 59.51 | 2.25% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -6.50% | SGD 9.2B | SGD 175.30 | 1.25% up | 6% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -9.67% | SGD 9.2B | SGD 83.96 | 4.15% down | 10% down | ||
| 49 | Abbott LaboratoriesABT · Health Care | -15.7% | SGD 232.4B | SGD 134.20 | 0.58% down | 16% down | ||
| 50 | Novo NordiskNVO · Health Care | -17.2% | SGD 221.3B | SGD 50.22 | 1.42% down | 17% down | ||
| 51 | CytokineticsCYTK · Health Care | -19.2% | SGD 9.3B | SGD 66.49 | 0.27% up | 19% down | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -19.9% | SGD 6.2B | SGD 35.84 | 0.25% down | 20% down | ||
| 53 | PTC TherapeuticsPTCT · Health Care | -21.2% | SGD 6.3B | SGD 75.36 | 3.16% down | 21% down | ||
| 54 | ZoetisZTS · Health Care | -26.2% | SGD 42.4B | SGD 104.38 | 5.59% down | 26% down | ||
| 55 | Madrigal PharmaceuticalsMDGL · Health Care | -26.6% | SGD 11.9B | SGD 512.60 | 0.34% down | 27% down | ||
| 56 | ABIVAXABVX · Health Care | -31.8% | SGD 9.1B | SGD 104.20 | 3.79% down | 32% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -36.2% | SGD 10.9B | SGD 13.66 | 0.67% up | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.0% | SGD 40.9B | SGD 186.65 | 20.58% up | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -41.0% | SGD 4B | SGD 20.80 | 0.92% down | 41% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -62.5% | SGD 5.9B | SGD 35.17 | 0.62% down | 63% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.5% | SGD 25.6B | SGD 190.99 | 1.06% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2920 SGD).
Questions and answers
Which health care pharmaceutical companies rank first by one-year price change?
Erasca (+395%), Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%) are the top three of the 61 health care pharmaceutical companies ranked by one-year price change as of 19 Nov 2026, 21:37 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by one-year price change have a combined market value of SGD 6.41T as of 19 Nov 2026, 21:37 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care pharmaceutical companies by one-year price change”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.